Skip to main content
Erschienen in: Supportive Care in Cancer 5/2013

01.05.2013 | Short Communication

Validation of the Chinese version of the Resilience Scale and its cutoff score for detecting low resilience in Chinese cancer patients

verfasst von: Jun Tian, Jin Sheng Hong

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aim to investigate the reliability and validity of the Chinese version of the Resilience Scale (RS-14) and to determine the cutoff score of the RS-14 for screening Chinese cancer patients with low resilience.

Methods

The current study was divided into two studies. In the first study, we randomly selected 625 people and obtained their scores in the Chinese version of the RS-14 and SF-36 using cross-sectional survey. We then calculated the validity and reliability of the Chinese version of the RS-14. In the second study, we selected 970 hospital cancer patients diagnosed during 2010 to 2011 and assessed for their resilience once and for anxiety, depression, and quality of life on two occasions. We determined the cutoff score of the RS-14 based on the maximum Youden Index, with the scores of anxiety and depression as gold standards.

Results

The correlation coefficients for inter-items were in the range of 0.23 to 0.68 (P < 0.001), whereas those for the item–scale were in the range of 0.62 to 0.82 (P < 0.001). Two factors represent the factor structure of the RS-14. The correlation coefficient between the RS-14 and SF-36 scores was 0.82 (P < 0.001). The split-half reliability and test–retest reliability of the RS-14 were both 0.82 (P < 0.001), and the internal consistency Cronbach's α was 0.93. The cutoff score of 64 was obtained for screening cancer patients with low resilience (sensitivity and specificity were 0.74 and 0.71, respectively).

Conclusion

The Chinese version of the RS-14 has good validity and reliability, and it can measure the resilience of Chinese people. The cutoff score of 64 for the RS-14 is appropriate for detecting cancer patients with low resilience in order to decrease psychological stress and improving quality of life. Health care nurses can screen and detect cancer patients with low resilience based on the said cutoff score to timely provide psychological care and interventions for the patients.
Literatur
2.
Zurück zum Zitat Efficace F, Bottomley A, van Andel G (2003) Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 97:377–388PubMedCrossRef Efficace F, Bottomley A, van Andel G (2003) Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 97:377–388PubMedCrossRef
3.
Zurück zum Zitat Lawford J, Eiser C (2001) Exploring links between the concepts of quality of life and resilience. Pediatr Rehab 4(4):209–216 Lawford J, Eiser C (2001) Exploring links between the concepts of quality of life and resilience. Pediatr Rehab 4(4):209–216
4.
Zurück zum Zitat Richardson GE (2002) The metatheory of resilience and resiliency. J Clin Psychol 58:307–321PubMedCrossRef Richardson GE (2002) The metatheory of resilience and resiliency. J Clin Psychol 58:307–321PubMedCrossRef
5.
Zurück zum Zitat Yi JP, Smith RE, Vitaliano PP (2005) Stress-resilience, illness, and coping: a person-focused investigation of young women athletes. J Behav Med 28(3):257–265PubMedCrossRef Yi JP, Smith RE, Vitaliano PP (2005) Stress-resilience, illness, and coping: a person-focused investigation of young women athletes. J Behav Med 28(3):257–265PubMedCrossRef
6.
Zurück zum Zitat Xi JZ, Sang B (2002) A general review of the studies of the resilience. Health Psychol J 10(4):314–318 Xi JZ, Sang B (2002) A general review of the studies of the resilience. Health Psychol J 10(4):314–318
7.
Zurück zum Zitat Bowen DJ, Morasca AA, Meischke H et al (2003) Measures and correlates of resilience. Women Health 38:65–76PubMedCrossRef Bowen DJ, Morasca AA, Meischke H et al (2003) Measures and correlates of resilience. Women Health 38:65–76PubMedCrossRef
8.
Zurück zum Zitat Strauss B, Brix C, Fischer S et al (2007) The influence of resilience on fatigue in cancer patients undergoing radiation therapy. J Cancer Res Clin Oncol 133:511–518PubMedCrossRef Strauss B, Brix C, Fischer S et al (2007) The influence of resilience on fatigue in cancer patients undergoing radiation therapy. J Cancer Res Clin Oncol 133:511–518PubMedCrossRef
9.
Zurück zum Zitat Wk H, Law CC, Yin J, Fu YT (2010) Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach. Health Psychol 29(5):484–495CrossRef Wk H, Law CC, Yin J, Fu YT (2010) Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach. Health Psychol 29(5):484–495CrossRef
10.
Zurück zum Zitat Wagnild GM, Young HM (1993) Development and psychometric evaluation of the Resilience Scale. J Nurs Meas 1(2):165–178PubMed Wagnild GM, Young HM (1993) Development and psychometric evaluation of the Resilience Scale. J Nurs Meas 1(2):165–178PubMed
11.
Zurück zum Zitat Ahern NR, Kiehl EM, Sole ML, Byers J (2006) A review of instruments measuring resilience. Issues in Compr Nurs 29(2):103–125CrossRef Ahern NR, Kiehl EM, Sole ML, Byers J (2006) A review of instruments measuring resilience. Issues in Compr Nurs 29(2):103–125CrossRef
12.
Zurück zum Zitat Wagnild GM (2009) The Resilience Scale user's guide for the US English version of the Resilience Scale and the 14-item Reselience Scale (RS-14). The Resilience Center, Montana Wagnild GM (2009) The Resilience Scale user's guide for the US English version of the Resilience Scale and the 14-item Reselience Scale (RS-14). The Resilience Center, Montana
13.
Zurück zum Zitat Bai GT, Ma YW, Jiang L (2009) A recent progress of the SF-36 in the world. J Clin Res 26(12):2367–2369 Bai GT, Ma YW, Jiang L (2009) A recent progress of the SF-36 in the world. J Clin Res 26(12):2367–2369
14.
Zurück zum Zitat Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue, Beijing Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue, Beijing
15.
Zurück zum Zitat Zigmond AS, Snaith PR (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef Zigmond AS, Snaith PR (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef
16.
Zurück zum Zitat Leung CM, Ho S, Kan CS, Hung CH, Chen CN (1993) Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J psychsom 40:29–34 Leung CM, Ho S, Kan CS, Hung CH, Chen CN (1993) Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J psychsom 40:29–34
19.
Zurück zum Zitat Damásio BF, Borsa JC (2011) 14-item Resilience Scale (RS-14): psychometric properties of the Brazilian version. J Nurs Meas 19(3):131–145PubMedCrossRef Damásio BF, Borsa JC (2011) 14-item Resilience Scale (RS-14): psychometric properties of the Brazilian version. J Nurs Meas 19(3):131–145PubMedCrossRef
20.
Zurück zum Zitat Nishi D, Uehara R, Kondo M, Matsuoka Y (2010) Reliability and validity of the Japanese version of the Resilience Scale and its short version. BMC Res Notes 3:310PubMedCrossRef Nishi D, Uehara R, Kondo M, Matsuoka Y (2010) Reliability and validity of the Japanese version of the Resilience Scale and its short version. BMC Res Notes 3:310PubMedCrossRef
Metadaten
Titel
Validation of the Chinese version of the Resilience Scale and its cutoff score for detecting low resilience in Chinese cancer patients
verfasst von
Jun Tian
Jin Sheng Hong
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1699-x

Weitere Artikel der Ausgabe 5/2013

Supportive Care in Cancer 5/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.